Overexpression of LPCAT in bone marrow-derived cells attenuates sickling, hemolysis, inflammation and tissue damage by reducing LysoPC in erythrocytes and circulating arachidonic acid in SCD chimeras. Here, LPCAT1 is linked to Schnyder corneal dystrophy.